Magtein®
The only form of magnesium with published research demonstrating it crosses the blood-brain barrier and increases brain magnesium levels, with preclinical evidence for increased synaptic density in the prefrontal cortex and hippocampus.
Primacy Research
What Magtein® Does For You
Brain-Bioavailable Magnesium
The only magnesium form clinically shown to cross the blood-brain barrier — developed at MIT specifically to deliver magnesium where it matters most: inside neurons and synapses.
Increased Synaptic Density
Elevates brain Mg²⁺ concentrations by 7–15%, driving increased presynaptic puncta in the hippocampus and prefrontal cortex — the structural foundation of memory and executive function.
Memory Gains Observed in Clinical Trials
Three human RCTs show significant improvements in overall cognition, working memory, and reaction time — with measurable results in as few as 30 days of supplementation.
Brain Age Reversal
The 2025 Lopresti trial showed a 7.5-year reduction in brain cognitive age after just 6 weeks. The 2016 Liu trial demonstrated a 9-year reversal in executive function measures.
Neural Stem Cell Support
Preclinical models show that sustained brain magnesium elevation halts age-related decline in neural stem cell self-renewal — supporting ongoing neurogenesis beyond acute cognitive benefits.
Your Brain Is Starving for Magnesium
Magnesium is required as a cofactor for over 300 enzymatic reactions. Yet roughly half the population doesn't consume the recommended daily amount — and standard magnesium supplements can't meaningfully raise levels where it matters most: inside the brain.
The Bioavailability Gap
Common magnesium forms (oxide, citrate, glycinate) raise serum levels but have not been demonstrated to meaningfully increase brain magnesium levels in published research. Your brain stays depleted even when your bloodwork looks normal.
Synaptic Degradation
Low brain magnesium weakens the NMDA receptor gating mechanism that controls synaptic plasticity — the foundation of learning, memory, and cognitive adaptation.
Accelerated Cognitive Aging
Without adequate brain magnesium, synaptic density in the prefrontal cortex and hippocampus declines earlier and faster — degrading executive function and memory consolidation.
How Magtein® Works
Magtein® was developed at MIT specifically to solve the brain bioavailability problem. The L-threonate ligand — a metabolite of vitamin C — facilitates magnesium transport across the BBB via glucose transporters.
BBB Penetration via Glucose Transporters
The L-threonate molecule binds to glucose transporters on the blood-brain barrier, carrying magnesium ions into the CNS with significantly higher efficiency than other magnesium salts.
Elevation of Brain Magnesium Concentration
Once inside the brain, Magtein® converts into active Mg²⁺ ions, increasing synaptic magnesium concentrations by 7–15% in preclinical models — a range no other commercial magnesium form has demonstrated in research.
NMDA Receptor Optimization
Elevated synaptic Mg²⁺ is thought to restore proper NMDA receptor gating — blocking pathological over-activation (excitotoxicity) while enabling appropriate activation during learning, which may trigger long-term potentiation (LTP).
BDNF Upregulation & Synaptic Density
In preclinical models, the optimized NMDA signaling cascade increases brain-derived neurotrophic factor (BDNF) expression and density of presynaptic puncta in the hippocampus and prefrontal cortex — the structural basis of improved memory and executive function.
Neural Stem Cell Proliferation
Long-term magnesium elevation via Magtein® has been shown in preclinical models to halt age-related decline in neural stem cell (NSC) self-renewal, supporting ongoing neurogenesis.
What the Research Shows
Magtein® is backed by multiple randomized, double-blind, placebo-controlled trials across different populations and age groups.
Lopresti & Smith (2025). Frontiers in Nutrition, 12:1729164. Adults aged 18–45, 2g/day for 6 weeks.
Zhang et al. (2022). Nutrients, 14(24):5235. Healthy adults aged 18–65, 2g/day for 30 days.
Liu et al. (2016). Journal of Alzheimer's Disease, 49:971–990. MMFS-01 (Magtein®-based formula), 12-week supplementation in adults with cognitive complaints.
Your Daily Dose in APEX
Why this dose works: Published research on Magtein® shows that effective elemental magnesium levels for cognitive benefit were 108–144 mg/day — well below the RDA. APEX delivers 109 mg of elemental Mg specifically through the BBB-crossing L-threonate pathway, targeting the brain directly rather than relying on systemic magnesium levels alone. APEX also includes 60 mg additional elemental Mg from Di-Magnesium Malate for Krebs cycle / ATP support — bringing total APEX magnesium to ~169 mg (40% DV).
Combined Daily Magnesium — APEX + RESET Protocol
Combined supplemental magnesium is engineered to stay just under the 350 mg Tolerable Upper Intake Level (UL) for supplemental sources. Three chelated forms target three distinct absorption pathways — BBB transport (Magtein®), PepT1 dipeptide uptake (Bisglycinate), and organic acid/Krebs cycle transport (Di-Magnesium Malate, delivered in both AM and PM).
How Magtein® Connects Across the System
Magtein® doesn’t work in isolation. Inside the Primacy protocol, it sits at the intersection of four major functional pathways spanning both APEX and RESET.
Triple BDNF Amplification
Magtein® increases BDNF expression through NMDA receptor optimization. CognatiQ® and Sabroxy® upregulate BDNF through complementary mechanisms — coffee fruit polyphenols and oroxylin A, respectively. Together, these three ingredients create a multi-pathway BDNF amplification system that no single compound can achieve alone.
Synaptic Membrane Triad
Magtein® increases synaptic density, but new synapses need structural material. Citicoline and Uridine supply the building blocks for phosphatidylcholine synthesis (the Kennedy pathway), forming the membranes that house those new synaptic connections. Magtein® creates the demand; Citicoline + Uridine supply the materials.
BDNF → Repair Cycle (Circadian)
APEX upregulates BDNF and drives synaptic formation during the day. RESET provides the structural substrates — Glycine for deep sleep phases, AvailOm® DHA for membrane repair — that consolidate those new connections overnight. The daytime signal (BDNF) needs the nighttime repair cycle to become permanent architecture.
Mitochondrial Continuity
APEX provides Di-Magnesium Malate for daytime Krebs cycle energy and ATP production under cognitive load. RESET continues mitochondrial support overnight with Di-Magnesium Malate plus Ubiqsome® CoQ10 for cellular energy replenishment. Magnesium is a required cofactor for ATP synthesis — Magtein® is designed to ensure the brain compartment specifically stays loaded.
Key Takeaways
The Only Brain-Bioavailable Magnesium
Magtein® is the only commercially available magnesium form demonstrated to cross the blood-brain barrier and meaningfully increase brain magnesium concentrations in published research.
Studied in Clinical Trials Across Populations
Three RCTs spanning ages 18–65+ show improvements in overall cognition, working memory, reaction time, and brain cognitive age — with results in as few as 30 days.
Multi-Pathway Mechanism
Magtein® works through NMDA receptor optimization, BDNF upregulation, increased synaptic density, and neural stem cell support — not just one mechanism, but a cascading system of structural brain benefits.
Amplified by the Full Primacy System
Inside APEX, Magtein® connects to the BDNF amplification stack, the Kennedy pathway membrane triad, and the mitochondrial energy system — then hands off to RESET for overnight consolidation. It’s not a standalone ingredient; it’s a hub in a 24-hour cognitive architecture.
Frequently Asked Questions
What is Magtein®?
Magtein® is a patented form of magnesium L-threonate developed at the Massachusetts Institute of Technology (MIT). The L-threonate ligand — a metabolite of vitamin C — facilitates transport of magnesium across the blood-brain barrier via glucose transporters, making it the only commercially available magnesium form demonstrated to meaningfully raise brain magnesium concentrations in published research.
How is Magtein® different from magnesium glycinate?
Magnesium glycinate is well-absorbed systemically and is often used for muscle relaxation and sleep support, but it has not been shown to significantly cross the blood-brain barrier or raise brain magnesium levels. Magtein® is the only form with published human clinical data demonstrating increased synaptic density, improved cognitive function, and brain age reversal — effects that require magnesium to reach the CNS, not just the bloodstream.
What are the main benefits of Magtein®?
Magtein® supports cognitive performance through NMDA receptor optimization, BDNF upregulation, increased synaptic density in the hippocampus and prefrontal cortex, and neural stem cell support. Three human RCTs have demonstrated improvements in overall cognition, working memory, reaction time, and brain cognitive age — with results in as few as 30 days.
How does Magtein® work in the brain?
The L-threonate molecule binds to glucose transporters on the blood-brain barrier, carrying magnesium ions into the CNS. Once inside, elevated Mg²⁺ restores proper NMDA receptor gating — blocking excitotoxicity while enabling appropriate activation during learning. This triggers long-term potentiation (LTP), increases BDNF expression, and drives the formation of new synaptic connections.
What is the right dosage of Magtein®?
All published human RCTs used 2,000 mg of Magtein® per day, yielding approximately 144 mg of elemental magnesium. APEX delivers 1,551 mg per serving (~109 mg elemental Mg), which falls within the effective elemental range demonstrated in clinical trials (108–144 mg/day). APEX also includes additional magnesium from Di-Magnesium Malate for ATP support.
Can magnesium really improve brain health?
Standard magnesium forms improve serum levels but fail to meaningfully cross the blood-brain barrier — so your brain stays depleted even when bloodwork looks normal. Magtein® solves this with a BBB-crossing delivery mechanism. The clinical evidence shows improvements in memory, cognitive age, and working memory across three RCTs in adults aged 18–65+. For brain-specific benefits, the form of magnesium matters more than the dose.
References
- [1]Lopresti, A. L., & Smith, S. J. (2025). A randomized, double-blind, placebo-controlled trial investigating the effects of a magnesium L-threonate supplement on cognition in healthy young adults. Frontiers in Nutrition, 12, 1729164.View
- [2]Zhang, C., Hu, Q., Li, S., Dai, F., Qian, W., Hewlings, S., Yan, T., & Wang, Y. (2022). A Magtein®, magnesium L-threonate, -based formula improves brain cognitive functions in healthy Chinese adults. Nutrients, 14(24), 5235.View
- [3]Liu, G., Weinger, J. G., Lu, Z. L., Xue, F., & Sadeghpour, S. (2016). Efficacy and safety of MMFS-01, a synapse density enhancer, for treating cognitive impairment in older adults: A randomized, double-blind, placebo-controlled trial. Journal of Alzheimer’s Disease, 49, 971–990.View
Upgrade Your Neural Architecture
Magtein® is one of 28 active ingredients in APEX, engineered to work as a system — not a stack of standalone compounds.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.